Study objective-The aim was to determine whether survival December 1989 Regional differences in the allocation of health services resources, or their use, or regional variations in health status, are used to indicate equity, one of the dimensions of quality of health care. 1-3 As a rule in clinical oncology the outcome of the treatnent indicates quality, and is given in terms of survival. The survival of a cancer patient depends on the characteristics of the patient, on the biology of the disease, and in part on the quality of the medical services. Some part of the differences in the survival rates of cancer patients is due only to random variation.
identified. Of these, 0-5% of breast cancers and 4-1% ofprostatic cancers were excluded because diagnosis was based only on necropsy findings or because the only information available was from the death certificate.
Measurements and main results-There was a large variation in rates, ranging from 59% to 76% for breast cancer, and from 30% to 65% for prostatic cancer. However, after accounting for age of patient and extent of disease, the standardised differences for prostatic cancer closely followed random distribution, indicating equal results of treatment in different areas. For breast cancer there was more variation than expected by chance and patients resident in any of the university central hospital districts with modern radiotherapy equipment survived better than other patients.
Conclusions-There is little indication that large variations in crude mortality rates from these two cancers in different parts of Finland are due to inequalities of medical care, though a small effect on breast cancer survival which might be care related was shown.
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The purpose of this paper was to determine (1) whether the survival of cancer patients in Finland varies with their place ofresidence, and (2) Even if the quality of treatment of the cancer patients was the same, ie, the theoretical survival rates of patients by hospital districts were identical, the observed rates would not be identical because of a random variation and confounding effects.
Confounding occurs if a geographically varying factor is related to survival. Selected confounders related to disease and the patient were considered. Confounding due to primary site of the tumour and extent of the disease was controlled for by analysing the survival separately for selected primary sites (breast and prostate) and for localised and non-localised tumours. The classification of stage was based on the stage at time of diagnosis reported by the clinician who had made the diagnosis. The confounding effect of age was eliminated in two stages: relative survival rates eliminate the effect of age related general mortality, and indirect adjustment" for age was used to eliminate the cancer related differences by age in survival rates.
The indicator for true equality in the survival rates is the distribution of standardised differences (Dj):
where E(Rj) is the expected relative survival rate, which is based on the total patient population over all hospital districts. The methodology has been described and discussed in detail in the article by Hakama et al. 4 The distribution of the standardised differences should follow approximately the normal probability law, with mean = 0 and standard deviation = 1, on the assumption ofequal theoretical survival in each of the hospital districts and only chance affecting the variation. Because there are 21 hospital districts in Finland, the expected number of standardised survival differences exceeding 2 in absolute value is one. Systematic variation will express itself in wider The lowest five year observed survival rate was 19-5% and the highest 42-20. The five year relative survival rates were between 30.000 and 64-6% (table) . Two of the standardised differences of age adjusted five year relative survival rates were not between the limits -2 and 2 ( fig 2) . There was a large difference of -43 and 4 0 between these two outliers. The standardised differences were not related to the existence of a university clinic. When survival rates were analysed by the stage ofdisease at diagnosis, much of the difference for the two outlier districts disappeared (fig 2) . There was no indication of variation greater than expected by chance.
Discussion
Finland is geographically variable: the population density differs by two orders of magnitude from the south to the north, the climate has substantial variations between the north and south, and social structure is correlated with geography. The local municipalities are responsible for the provision of the health services, with expenditure subsidised by the central government. Several municipalities are combined to form a hospital district.
The results were based on 17 000 breast cancer patients and on 9000 prostatic cancer patients. Compared to clinical trials on which the routine use and preferences on clinical treatment are based these figures are large indeed. The five year relative survival rates varied from 59 to 7600 for breast cancer patients and from 30 to 6500 for prostatic cancer patients. Most of this substantial variation can, however, be accounted for by confounding and by random variation. The method used here for eliminating the confounding effect of age and stage and to evaluate the random variation has been studied earlier and compared with another method based on proportional hazards' model.4 It was concluded that with both methods it was possible to detect the systematic variation in survival. Despite the fact that the regression analysis method was more sensitive and more factors could simultaneously be taken into acount, in the present application the method used was also successful in detecting more than random variation.
In the case of breast cancer patients with localised tumours, variation exceeding that expected by chance was due to a single outlier. The distribution of standardised differences was wide for female breast cancer patients with nonlocalised tumours. This pattern showed more variation than expected by chance. For prostatic cancer the apparent systematic variation almost disappeared after adjusting for the obvious confounder of age. In the analysis without stratification by stage, two hospital districts appeared to differ from the others, patients in one district doing very well and patients in the other rather worse.
The more than chance variation in survival for breast cancer patients may be due to incomplete removal of confounding factors or to inequality in health services. There were systematic differences in the type and resources between the hospitals which can be related to the survival of patients residing in the geographical area covered by the hospital district. If, in Finland, a hospital with a cancer unit does not have radiation treatment facilities, the patient is referred for that kind of treatment to the nearest hospital with such equipment, and the overall treatment policy tends to become very similar throughout the country. However, although such referral is common, the selection of radiation treatment for a patient residing in a radiation equipped hospital district is likely to be different from that for a patient residing in an area without its own facilities for radiation treatment. Futhermore, the effect of radiation equipment should be site specific and rather direct for breast cancer, in which radiation treatment is common, and less obvious or indirect for prostatic cancer, where radiation treatment is much less common.
There were only minor differences in survival for breast cancer patients associated with the existence of radiation equipment. This could imply that the organisation functions well and patients are treated by radiation equally effectively irrespective ofthe local facility for such treatment. Therefore the centralisation of the radiotherapy facilities did not seem to have an effect on the survival of a patient. The second alternative is that radiation treatment does not have any overall effect on survival ofpatients with breast cancer. It is also possible that the method used is not sensitive enough to detect small differences in survival. 4 Survival was somewhat better for breast cancer patients resident in university hospital districts. The differences indicate either better treatment due to greater expertise or more indirect effects related to the patients or to the environment. The lead time from first symptoms to diagnostic confirmation may be shorter in university hospital districts due, perhaps, to better diagnostic services and procedures or to better cancer consciousness in the population. This assumes that the crude adjustment by stage into localised and non-localised cases only was not enough to remove all the bias from this source. It is also possible that the results without classification of stage are less subject to bias, because in some areas the metastatic tumours may have mistakenly been classified as localised more often than in some other areas. This would tend to bias the survival rates downwards for both the localised and the non-localised group of patients.
There is also geographical variation in the incidence of cancer in Finland.'3 People living in the areas with a university hospital are generally of higher socioeconomic status than others and the environmental exposures and personal habits related to cancer risk differ systematically between the university hospital districts and other areas in Finland. If the speed of growth of the tumour is related to the aetiology, then survival rates and university hospitals will be spuriously related.
In conclusion, a major part ofthe large variation in survival of breast cancer patients could be accounted for by chance. There was only minor variation in survival, which could possibly be attributed to health services. The differences in survival were related more to residing in a university hospital district than to residing in a district equipped with a hospital radiotherapy unit. If the differences are due to treatment, the results imply that they are more likely to be due to non-radiation than to radiation treatment. For prostatic cancer the large differences in survival rates of from 30% to 650% were due to confounding and to chance, and there was no indication of differences induced by treatment. Therefore, in spite of the large variation in crude survival, there were only minor indications of inequality in cancer treatment in Finland in terms of survival of the patient with breast or prostatic cancer, because most of the variation in survival could be accounted for by chance variation and by confounding of factors not related to health services.
